Right - and it's an attractive type of stock for investment firms. The safe pick in a boom industry like this is not the scientists researching the next strain, but the manufacturers selling the equipment.
It's a one stop shop. No matter how far the science comes, it's still cheaper for our PBR to produce the strain.